Company:  ADAMIS PHARMACEUTICALS CO ... (ADMP)
Form Type:  SC 13G
Filing Date:  2/28/2020 
CIK:  0000887247 
Address:  11682 EL CAMINO REAL
SUITE 300
 
City, State, Zip:  SAN DIEGO, California 92130 
Telephone:  (858) 997-2400 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.49  
Change: 
-0.0137 (-2.73%)  
Trade Time: 
May 28  
Market Cap: 
$36.06M
Trade ADMP now with 

© 2020  
Description of Business
Adamis Pharmaceuticals Corporation ("we," "us," "our," "Adamis" or the "company") is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including respiratory disease, allergy and opioid overdose. Our products and product candidates in the allergy, respiratory, and opioid overdose markets include: SYMJEPI(TM) (epinephrine) Injection 0.3mg, which was approved by the U.S.
Register and access this filing in:     
  FORM SC 13G